Buspirone enhances immobility in the forced swim test in mice

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 3, 1996, Pages 445-451

  Kitamura, Yoshihisa ^a   Nagatani, Tadashi ^a  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

5 Hydroxytryptamine (5 HT)(1A) receptor; 8 OH DPAT; Buspirone; Forced swim test

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 1 (2 PYRIMIDINYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; APOMORPHINE; BUSPIRONE; DOPAMINE RECEPTOR BLOCKING AGENT; FENCLONINE; HALOPERIDOL; PRAZOSIN; PROADIFEN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SPIPERONE; SPIROXATRINE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; FORCED SWIMMING TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTI-ANXIETY AGENTS; BUSPIRONE; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SWIMMING;

ANIMALIA;

EID: 0030296810     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00116-5     Document Type: Article

References (30)

1. 1. Ander, M. W. Enhancement of drug metabolism. Ann. Rev. Pharmacol. 11:37-52; 1971.
2. 1 receptors reduces immobility time of rats in the forced swimming test: Implication for antidepressant activity. Eur. J. Pharmacol. 148:301-307; 1988.
3. 3. Caccia, S.; Garattini, S.; Mancinell, A.; Muglia, M. Identification and guantiation of 1-(2-pyrimidinyl)-piperazine, an active metabolite of the anxiolytic agent buspironem in rat plasma and brain. J. Chromatogr. 252:310-314; 1982.
4. 1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur. J. Pharmacol. 158:53-59; 1988.
5. 5. Cervo, L.; Grignashi, G.; Samanin, R. Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: Involvement of a metabolite. Life Sci. 43:2095-2102; 1988.
6. 2-adrenoceptor blockade prevents the effect of desipramine in the forced dwimming test. Eur. J. Pharmacol. 175:301-307; 1990.
7. 1A receptor agonist. Eur. J. Pharmacol. 144:223-229; 1987.
8. 1A receptor antagonist NAN-190 on rat brain serotonergic transmission. Eur. J. Pharmacol. 204: 71-77; 1991.
9. 9. Dourish, C. T.; Huston, P. H.; Curzon, G. Low doses of the putative serotonin agonist 8-hydroxy-(2-di-n-propylamino) tetraline (8-OH-DPAT) elict feeding in the rat. Psychopharmacology 86:197-294; 1985.
10. 1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Eur. J. Pharmacol. 154:339-341; 1988.
11. 11. Hicks, P. B. The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci. 47:1609-1615; 1990.
12. 12. Hjorth, S. Hypothemia in the rat induced by the potent serotonergic agent 8-OH-DPAT. J. Neural Transm. 61:131-135; 1985.
13. 13. Kostowski, W.; Plaźnik, A.: Stefański, R. Intra-hipocampal buspirone in animal model of anxiety. Eur. J. Pharmacol. 168:393-396, 1989.
14. 1A receptors. Br. J. Pharmacol. 108: 669-677; 1993.
15. 15. Neal-Beliveau, B. S.; Joyce, J. N.; Lucki, I. Serotonergic involvement in haloperidol-induced catalepsy. J. Pharmacol. Exp. Ther. 265:207-217; 1992.
16. 16. Porsolt, R. D.; Pichon, M. L. E.; Jalfre, M. Behavioral despair in mice: A primary screening test for antidepressant. Arch. Int. Pharmacodyn. 299:327-336; 1977.
17. 17. Przegaliński, E.; Ismaiel, A. M.; Chojnacka-Wójcik, E.; Budziszewska, B.; Tatarczyńska, E.; Blaszcyńska, E. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(di-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat. Neuropharmacology 29:521-526; 1990.
18. 18. Przegaliński, E.; Tatarczyńska, E.; Chojnacka-Wójcik, E. Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen, J. Psychopharmacol. 4:204-209; 1990.
19. 19. Riblet, L. A.; Taylor, D. P.; Eison, M. S.; Syanton, H. C. Pharmacology and neurochemistry of buspirone. J. Clin. Psychiatry 43:11-16; 1982.
20. 20. Robinson. D. S. Buspirone in the treatment of anxiety. In: Godfrey, T., ed. Buspirone: Mechanisms, clinical aspects. San Diego: Academic Press; 1991:3-17.
21. 1A partial agonists in depression: A composite analysis of buspirone in the treatment of depression. J. Clin. Psychopharmacol. 10:67S-76S; 1990.
22. 22. Ruat, M.; Traiffort, E.; Tardivel-Lacombe, J.; Diaz, J.; Arrang, J. M.; Schwartz, J. C. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. USA 90:8547-8551; 1993.
23. 23. Shimizu, H.; Hirose, A.; Tatsuno, T.; Nakamura, M.; Katsube, J. Pharmacological properties of SM-3997: A new anxioselective anxiolytic candidate. Japan. J. Pharmacol. 45:493-500; 1987.
24. 24. Tatarczyńska, E.; Chojnacka-Wójcik, E. Effects of 8-OH-DPAT and ipsapirone in the tests used for evaluation of the antidepressant action. Pol. J. Pharmacol. Pharm. 41:321-330; 1989.
25. 1 receptor and of catecholaminergic system in the behavioural response to 8-hydroxy-2-(di-n-propyl-amino) tetraline of the rat. Eur. J. Pharmacol. 106:271-282; 1985.
26. 1A subtypes. Eur. J. Pharmacol. 113:463-464; 1985.
27. 1A agonists measured with the forced swim test. Psychopharmacology 101:497-504; 1990.
28. 28. Wijngaargen, I. V.; Tulp, M. T. M.; Soudijn, W. The concept of selectivity in the 5-HT receptor research. Eur. J. Pharmacol. 188:301-312; 1990.
29. 29. Witkin, J. M.; Barrett, J. E. Interaction of buspirone and dopaminergic agents on punished behavior of pigeons. Pharmacol. Biochem. Behav. 24:751-756; 1986.
30. 1A receptor agonist. 8-OH-DPAT? Eur. J. Pharmacol. 193:253-256; 1991.